A phase 1b study of RXDX-105, a VEGFR-sparing potent RET inhibitor, in RETi-naïve patients with RET fusion-positive NSCLC Meeting Abstract
| Authors: | Drilon, A. E.; Liu, S.; Doebele, R.; Rodriguez, C.; Fakih, M.; Reckamp, K. L.; Bazhenova, L.; Cho, B. C.; Kowack, E.; Oliver, J.; Multani, P.; Ahn, M. J. |
| Abstract Title: | A phase 1b study of RXDX-105, a VEGFR-sparing potent RET inhibitor, in RETi-naïve patients with RET fusion-positive NSCLC |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx440.012 |
| Language: | English |
| ACCESSION: | WOS:000411324005072 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx440.012 |
| Notes: | Meeting Abstract: LBA19 -- Appears on page 612 of the abstract book -- Source: Wos |
